Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review
Journal of Psychedelic Studies January 16, 2023 Madeline Brendle, Anya Ragnhildstveit, Matthew Slayton et al. 7 citations
Ketamine and esketamine have garnered interest in both psychiatric research and clinical practice for treatment-resistant depression (TRD). In this review, we examined registered trials investigating the therapeutic use of ketamine or esketamine for TRD, with the aim of characterizing emerging trends and knowledge gaps.The ClinicalTrials.gov electronic registry and results database was queried...